Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ADVANCED ENZYME TECHNOLOGIES vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ADVANCED ENZYME TECHNOLOGIES   TEVA PHARMA
EQUITY SHARE DATA
    ADVANCED ENZYME TECHNOLOGIES
Mar-23
TEVA PHARMA
Dec-13
ADVANCED ENZYME TECHNOLOGIES/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs3283,483-   
Low Rs2253,026-   
Sales per share (Unadj.) Rs48.31,998.8-  
Earnings per share (Unadj.) Rs9.3124.9-  
Cash flow per share (Unadj.) Rs12.4286.4-  
Dividends per share (Unadj.) Rs5.00109.31-  
Avg Dividend yield %1.83.4 53.8%  
Book value per share (Unadj.) Rs110.52,220.3-  
Shares outstanding (eoy) m111.82848.00-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x5.71.6 351.5%   
Avg P/E ratio x29.826.1 114.3%  
P/CF ratio (eoy) x22.311.4 196.1%  
Price / Book Value ratio x2.51.5 170.9%  
Dividend payout %53.887.5 61.5%   
Avg Mkt Cap Rs m30,9392,759,528 1.1%   
No. of employees `000NA44.9 0.0%   
Total wages/salary Rs m1,1480-   
Avg. sales/employee Rs Th037,712.8-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th02,355.9-  
INCOME DATA
Net Sales Rs m5,4061,695,000 0.3%  
Other income Rs m2550-   
Total revenues Rs m5,6611,695,000 0.3%   
Gross profit Rs m1,534464,177 0.3%  
Depreciation Rs m350137,008 0.3%   
Interest Rs m3533,293 0.1%   
Profit before tax Rs m1,404293,876 0.5%   
Minority Interest Rs m01,335 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-192,913 -0.0%   
Tax Rs m365-3,588 -10.2%   
Profit after tax Rs m1,039105,885 1.0%  
Gross profit margin %28.427.4 103.6%  
Effective tax rate %26.0-1.2 -2,130.8%   
Net profit margin %19.26.2 307.5%  
BALANCE SHEET DATA
Current assets Rs m7,2211,144,797 0.6%   
Current liabilities Rs m776998,360 0.1%   
Net working cap to sales %119.28.6 1,380.0%  
Current ratio x9.31.1 811.9%  
Inventory Days Days25591 280.6%  
Debtors Days Days6896 70.6%  
Net fixed assets Rs m6,884553,624 1.2%   
Share capital Rs m2244,172 5.4%   
"Free" reserves Rs m12,1270-   
Net worth Rs m12,3511,882,824 0.7%   
Long term debt Rs m78866,691 0.0%   
Total assets Rs m14,1053,873,619 0.4%  
Interest coverage x41.49.8 420.9%   
Debt to equity ratio x00.5 1.4%  
Sales to assets ratio x0.40.4 87.6%   
Return on assets %7.63.6 211.8%  
Return on equity %8.45.6 149.5%  
Return on capital %11.64.9 234.7%  
Exports to sales %17.30-   
Imports to sales %7.80-   
Net fx Rs m5180-   
CASH FLOW
From Operations Rs m1,404270,095 0.5%  
From Investments Rs m-2,982-95,706 3.1%  
From Financial Activity Rs m-258-323,998 0.1%  
Net Cashflow Rs m-1,709-149,608 1.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 83.44 Rs / USD

Compare ADVANCED ENZYME TECHNOLOGIES With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare ADVANCED ENZYME TECHNOLOGIES With: VINEET LABORATORIES  SHILPA MEDICARE  NEULAND LABS  SUVEN PHARMACEUTICALS  ALPA LAB  



Today's Market

Sensex Today Ends 189 Points Lower | IT Stocks Drag | REC Rallies 10%, Hitachi Energy 9% Sensex Today Ends 189 Points Lower | IT Stocks Drag | REC Rallies 10%, Hitachi Energy 9%(Closing)

After opening the day on positive note, Indian share markets reversed the trend as the session progressed and ended lower.